| A phase II study of adoptive immunotherapy using dendritic cells pulsed with tumor lysate in patients with hepatocellular carcinoma DH Palmer, RS Midgley, N Mirza, EE Torr, F Ahmed, JC Steele, ... Hepatology 49 (1), 124-132, 2009 | 641 | 2009 |
| Impaired bone marrow homing of cytokine-activated CD34+ cells in the NOD/SCID model F Ahmed, SJ Ings, AR Pizzey, MP Blundell, AJ Thrasher, TY Hong, ... Blood 103 (6), 2079-2087, 2004 | 79 | 2004 |
| Variable product purity and functional capacity after CD34 selection: a direct comparison of the CliniMACS®(v2· 1) and Isolex® 300i (v2· 5) clinical scale devices MJ Watts, TCP Somervaille, SJ Ings, F Ahmed, A Khwaja, K Yong, ... British journal of haematology 118 (1), 117-123, 2002 | 68 | 2002 |
| Tumor stroma as a target in cancer F Ahmed, JC Steele, JMJ Herbert, NM Steven, R Bicknell Current cancer drug targets 8 (6), 447-453, 2008 | 62 | 2008 |
| The productivity limit of manufacturing blood cell therapy in scalable stirred bioreactors R Bayley, F Ahmed, K Glen, M McCall, A Stacey, R Thomas Journal of tissue engineering and regenerative medicine 12 (1), e368-e378, 2018 | 35 | 2018 |
| Robo4 vaccines induce antibodies that retard tumor growth X Zhuang, F Ahmed, Y Zhang, HJ Ferguson, JC Steele, NM Steven, ... Angiogenesis 18 (1), 83-95, 2015 | 29 | 2015 |
| Production of erythrocytes from directly isolated or Delta1 Notch ligand expanded CD34< sup>+</sup> hematopoietic progenitor cells: process characterization, monitoring and … KE Glen, VL Workman, F Ahmed, E Ratcliffe, AJ Stacey, RJ Thomas Cytotherapy 15 (9), 1106-1117, 2013 | 22 | 2013 |
| p107 is active in the nucleolus in non-dividing human granulosa lutein cells C Green, R Chatterjee, HH McGarrigle, F Ahmed, NS Thomas Journal of Molecular Endocrinology 25 (3), 275-286, 2000 | 20 | 2000 |
| Storage of PBSC in liquid phase for 16 hours leads to occult progenitor cell damage only fully apparent after freeze thawing. MJ Watts, SJ Ings, C Balsa, F Ahmed, M Scott, K Richardson, DC Linch AMER SOC HEMATOLOGY 102 (11), 40A-40A, 2003 | 2 | 2003 |
| Variable product purity and functional capacity after CD34+ cell selection: A comparison of the CliniMACS and Isolex 300i clinical scale devices. MJ Watts, TCP Somervaille, SJ Ings, F Ahmed, A Khwaja, K Yong, ... Blood 96 (11), 773A-773A, 2000 | 2 | 2000 |
| The retinoblastoma family member, p107, is active in non‐dividing monocyte‐derived dendritic cells KM Ardeshna, F Ahmed, S Devereux, NSB Thomas British journal of haematology 112 (3), 655-657, 2001 | 1 | 2001 |
| The retinoblastoma family member, p107, is active in non‐dividing monocyte‐derived dendritic cells KM Ardeshna, F Ahmed, S Devereux, NSB Thomas British journal of haematology 112 (3), 655-657, 2001 | 1 | 2001 |
| Clinical scale depletion of CD3+ CD8+ expressing T-cells from mobilised donor PBSC products using the eligix High Density Magnetic Particle (HDM) device MJ Watts, SJ Ings, F Ahmed, R Smith, S Mackinnon, DC Linch BONE MARROW TRANSPL 27, S125-S125, 2001 | 1 | 2001 |
| Poor viability of freshly apheresed PBSC harvests: Implications for overnight storage before cryopreservation or additional manipulative procedures. F Ahmed, MJ Watts, SJ Ings, M Flynn, DC Linch Blood 96 (11), 380A-380A, 2000 | 1 | 2000 |
| Enabling Human Pluripotent Stem Cell Derived Megakaryocyte Manufacture EA Cheeseman, R Moore, M McCall, F Ahmed, T Moreau, C Ghevaert, ... Cytotherapy 18 (6), S17, 2016 | | 2016 |
| Homing and engraftment of CD34+ cells in theNOD/SCID model F Ahmed PQDT-Global, 2005 | | 2005 |
| Homing and engraftment of CD34+ cells in the NOD/SCID model. F Ahmed University of London, 2005 | | 2005 |
| Isolex 300i and CliniMACS clinical scale CD34 selection devices: A split harvest comparison MJ Watts, TCP Somervaille, SJ Ings, F Ahmed, A Khwaja, DC Linch LEUKEMIA 16 (3), 416-416, 2002 | | 2002 |
| Cytokine exposure impairs short-term homing of CD34 (+) cells in SCID/NOD mice: Influence of cell cycle status. F Ahmed, SJ Ings, A Pizzey, A Fahey, M Blundell, SJ Hardy, A Thrasher, ... BLOOD 98 (11), 644A-644A, 2001 | | 2001 |
